CLINICAL_TRIALS
trial_result
· 2019-12-05
Clinical Trial Update: Mexiletine in Sporadic Amyotrophic Lateral Sclerosis [Phase 2]
Summary
A Phase 2 trial evaluating mexiletine in sporadic amyotrophic lateral sclerosis has been completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Washington | Conditions: Sporadic Amyotrophic Lateral Sclerosis | Phase 2 | Status: COMPLETED | Results posted: 2019-12-05